U.S. flag An official website of the United States government
  1. Home
  2. Animal & Veterinary
  3. Products
  4. Animal Food & Feeds
  5. Medicated Feeds
  6. Blue Bird Labels
  7. Sheep
  1. Medicated Feeds

Sheep

Breeding Sheep
Growing Sheep
Sheep (Multiple Classes)


Marketing Status The following guide explains the marketing status categories used in the tables below:

  • OTC - Product is in over-the-counter marketing status and is not impacted by Guidance for Industry #213 (GFI #213)
  • VFD - Product is in Veterinary Feed Directive Status.

Breeding Sheep

Active Ingredient Proprietary Name NADA/ANADA Label Type Indications Marketing Status
Chlortetracyline CHLORMAX N046-699 Type C For reducing the incidence of (vibrionic) abortion caused by Campylobacter fetus infection susceptible to chlortetracycline. VFD (Effective 1/1/17)
Chlortetracycline AUREOMYCIN N048-761 Type B For reducing the incidence of (vibrionic) abortions caused by Campylobacter fetus infection susceptible to chlortetracycline in breeding sheep. VFD (Effective 1/1/17)
Chlortetracycline AUREOMYCIN N048-761 Type C For reducing the incidence of (vibrionic) abortions caused by Campylobacter fetus infection susceptible to chlortetracycline in breeding sheep. VFD (Effective 1/1/17)
Chlortetracycline CLTC N092-286 Type C For reducing the incidence of (vibrionic) abortions caused by Campylobacter fetus infection susceptible to chlortetracycline in breeding sheep. VFD (Effective 1/1/17)
Chlortetracycline PENNCHLOR N138-935 Type B For use in manufacturing medicated sheep feed VFD (Effective 1/1/17)
Chlortetracycline PENNCHLOR N138-935 Type C For reducing the incidence of (vibrionic) abortions caused by Campylobacter fetus infection susceptible to chlortetracycline in breeding sheep. VFD (Effective 1/1/17)
Chlortetracycline DERACIN A200-510 Type B For reduction in the incidence of (vibrionic) abortions caused by Campylobacter fetus infection susceptible to chlortetracycline in breeding sheep. VFD (Effective 1/1/17)
Chlortetracycline DERACIN A200-510 Type C For reduction in the incidence of (vibrionic) abortions caused by Campylobacter fetus infection susceptible to chlortetracycline in breeding sheep. VFD (Effective 1/1/17)

Back to the top

Growing Sheep

Active Ingredient Proprietary Name NADA/ANADA Label Type Indications Marketing Status
Chlortetracycline CHLORMAX N046-699 Type C For an increased rate of weight gain and improved feed efficiency. As of 1/1/17, this use is no longer approved
Chlortetracycline AUREOMYCIN N048-761 Type B For increased rate of weight gain and improved feed efficiency in growing sheep. As of 1/1/17, this use is no longer approved
Chlortetracycline AUREOMYCIN N048-761 Type C For increased rate of weight gain and improved feed efficiency in growing sheep. As of 1/1/17, this use is no longer approved

Back to the top

Sheep (Multiple Classes)

Active Ingredient Proprietary Name NADA/ANADA Label Type Indications Marketing Status
Decoquinate DECCOX N039-417 Type C For the prevention of coccidiosis in young sheep caused by Eimeria ovinoidalis, E. parva, E. bakuensis, and E. crandallis. OTC
Decoquinate DECCOX N039-417 Type C For the prevention of coccidiosis in young sheep caused by Eimeria ovinoidalis, E. parva, E. bakuensis, and E. crandallis. OTC
Decoquinate DECCOX N039-417 Type C For the prevention of coccidiosis in young sheep caused by Eimeria ovinoidalis, E. parva, E. bakuensis, and E. crandallis. OTC
Decoquinate DECCOX N039-417 Type B For the prevention of coccidiosis in young sheep caused by Eimeria ovinoidalis, E. parva, E. bakuensis, and E. crandallis. OTC
Decoquinate DECCOX N039-417 Type B For the prevention of coccidiosis in young sheep caused by Eimeria ovinoidalis, E. parva, E. bakuensis, and E. crandallis. OTC
Decoquinate (liquid) DECCOX N039-417 Type B For the prevention of coccidiosis in young sheep caused by Eimeria ovinoidalis, E. parva, E. bakuensis, and E. crandallis. OTC
Lasalocid (liquid) BOVATEC N096-298 Type B For prevention of coccidiosis caused by Eimeria ovina, E. crandallis, E. ovinoidalis (E. ninakohlyakimovae), E. parva, and E. intricata in sheep maintained in confinement. OTC
Lasalocid BOVATEC N096-298 Type B For prevention of coccidiosis caused by Eimeria ovina, E. crandallis, E. ovinoidalis (E. ninakohlyakimovae), E. parva, and E. intricata in sheep maintained in confinement. OTC
Lasalocid BOVATEC N096-298 Type C For prevention of coccidiosis caused by Eimeria ovina, E. crandallis, E. ovinoidalis (E. ninakohlyakimovae), E. parva, and E. intricata in sheep maintained in confinement. OTC
Neomycin Sulfate and Oxytetracycline NEO-TERRAMYCIN N094-975 Type B Increased rate of weight gain and improved feed efficiency As of 1/1/17, this use is no longer approved
Neomycin Sulfate and Oxytetracycline NEO-TERRAMYCIN N094-975 Type C Increased rate of weight gain and improved feed efficiency As of 1/1/17, this use is no longer approved
Neomycin Sulfate and Oxytetracycline NEO-TERRAMYCIN N094-975 Type B Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin VFD (Effective 1/1/17)
Neomycin Sulfate and Oxytetracycline NEO-TERRAMYCIN N094-975 Type C Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin VFD (Effective 1/1/17)
Neomycin Sulfate and Oxytetracycline NEO-OXTC N138-939 Type B For use in manufacturing medicated sheep feed VFD (Effective 1/1/17)
Neomycin Sulfate and Oxytetracycline NEO-OXTC N138-939 Type C For increased rate of weight gain and improved feed efficiency. As of 1/1/17, this use is no longer approved
Neomycin Sulfate and Oxytetracycline NEO-OXTC N138-939 Type C Treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline; treatment and control of colibacillosis (bacterial enteritis) caused by E. coli susceptible to neomycin VFD (Effective 1/1/17)
Oxytetracycline TERRAMYCIN N008-804 Type B For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline. VFD (Effective 1/1/17)
Oxytetracycline TERRAMYCIN N008-804 Type C For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline. VFD (Effective 1/1/17)
Oxytetracycline OXTC N095-143 Type B For sheep for increased rate of weight gain and improved feed efficiency. As of 1/1/17, this use is no longer approved
Oxytetracycline OXTC N095-143 Type C For sheep for increased rate of weight gain and improved feed efficiency. As of 1/1/17, this use is no longer approved
Oxytetracycline OXTC N095-143 Type B For sheep for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline. VFD (Effective 1/1/17)
Oxytetracycline OXTC N095-143 Type C For sheep for treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline. VFD (Effective 1/1/17)
Oxytetracycline OTC N138-938 Type B For use in manufacturing medicated sheep feed VFD (Effective 1/1/17)
Oxytetracycline OTC N138-938 Type C For increased rate of weight gain and improved feed efficiency in growing sheep. As of 1/1/17, this use is no longer approved
Oxytetracycline OTC N138-938 Type C For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to oxytetracycline. VFD (Effective 1/1/17)

Back to the top